The 14 analysts offering 12-month price forecasts for Health Catalyst Inc have a median target of 40.00, with a high estimate of 50.00 and a low estimate of 33.00. The median estimate represents a +11.61% increase from the last price of 35.84.
The current consensus among 15 polled investment analysts is to Buy stock in Health Catalyst Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.24
Reporting Date Aug 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.